[Benefits of functional imaging in radiotherapy].
Functional imaging with positron emission tomography (PET) is interesting to optimize radiotherapy planning, and probably to perform dose redistribution in many cancers. However, in 2015, fluorodeoxyglucose (FDG)-PET is validated only for therapy planning for lung cancer. The interest of dose painting, PET in non-lung cancers, the interest of other tracers (even PET hypoxia tracers), DW-MRI, and PET-MR for radiotherapy needs to be demonstrated in prospective multicentric phase III studies on large series of patients.
Département de médecine nucléaire, centre de lutte contre le cancer Henri-Becquerel, 1, rue d'Amiens, 76000 Rouen, France; FR CNRS 3638, laboratoire QuantIF (EA4108-Litis), rue d'Amiens, 76000 Rouen, France. Electronic address: Pierre.Vera@chb.unicancer.fr.
P
P
Vera
Département de médecine nucléaire, centre de lutte contre le cancer Henri-Becquerel, 1, rue d'Amiens, 76000 Rouen, France; Département de radiothérapie, centre de lutte contre le cancer Henri-Becquerel, rue d'Amiens, 76000 Rouen, France; FR CNRS 3638, laboratoire QuantIF (EA4108-Litis), rue d'Amiens, 76000 Rouen, France.
S
S
Thureau
D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000532:radiotherapy*; D057054:Molecular Imaging; D049268:Positron-Emission Tomography; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D061089:Radiotherapy, Image-Guided / Q000379:methods*
Hypoxia; Hypoxie; PET; Radiotherapy; Radiothérapie; TEP